Inhibitors of prenylation of Ras and other G-proteins and their application as therapeutics
- 21 September 2000
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 60 (8) , 1061-1068
- https://doi.org/10.1016/s0006-2952(00)00386-5
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Alendronate Is a Specific, Nanomolar Inhibitor of Farnesyl Diphosphate SynthaseArchives of Biochemistry and Biophysics, 2000
- Mechanism of Aminobisphosphonate Action: Characterization of Alendronate Inhibition of the Isoprenoid PathwayBiochemical and Biophysical Research Communications, 1999
- Farnesyl Pyrophosphate Synthase Is the Molecular Target of Nitrogen-Containing BisphosphonatesBiochemical and Biophysical Research Communications, 1999
- The Role of Geranylgeranylation in Bone Resorption and Its Suppression by Bisphosphonates in Fetal Bone Explants In Vitro: A Clue to the Mechanism of Action of Nitrogen-Containing BisphosphonatesJournal of Bone and Mineral Research, 1999
- Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including RasJournal of Bone and Mineral Research, 1998
- Ras Farnesyltransferase: A New Therapeutic TargetJournal of Medicinal Chemistry, 1997
- Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeuticCell, 1994
- PROTEIN ISOPRENYLATION AND METHYLATION AT CARBOXYL-TERMINAL CYSTEINE RESIDUESAnnual Review of Biochemistry, 1992
- Posttranslational modification of proteins by isoprenoids in mammalian cellsThe FASEB Journal, 1990
- Isoprenylated proteins in cultured cells: Subcellular distribution and changes related to altered morphology and growth arrest induced by mevalonate deprivationJournal of Cellular Physiology, 1987